LiaMoriguchi(Moriguchi)HalaszMD(She/Her)
Radiation Oncology • Seattle, WAProfessor and Gerlich Family Endowed Chair in Neuro-oncology
Dr. Halasz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1570 N 115th St
Seattle, WA 98133Phone+1 206-306-2800
Summary
- Dr. Lia Halasz is a radiation oncologist in Seattle, WA and is affiliated with multiple hospitals in the area, including UW Medicine/Harborview Medical Center, Fred Hutchinson Cancer Center, UW Medicine/University of Washington Medical Center, and UW Medicine/Northwest Hospital & Medical Center. She received her medical degree from Harvard Medical School and has been in practice 11 years. She is experienced in primary brain tumors, metastatic brain tumors, pediatric brain tumors, proton beam therapy, and radiation oncology. She has more than 60 publications and over 500 citings.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011- Brigham and Women's HospitalInternship, Internal Medicine, 2006 - 2007
Harvard Medical SchoolClass of 2006
Certifications & Licensure
WA State Medical License 2011 - 2026
MA State Medical License 2008 - 2013- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma.Patrick Roth, David Capper, Evan Calabrese, Lia M Halasz, Asgeir S Jakola
Neuro-Oncology Practice. 2025-02-01 - Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults...Mateo Ziu, Lia M Halasz, Priya U Kumthekar, Tresa M McGranahan, Simon S Lo
Journal of Neuro-Oncology. 2025-01-01 - The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma.Macarena I de la Fuente, Mehdi Touat, Martin J van den Bent, Matthias Preusser, Katherine B Peters
Neuro-Oncology. 2024-12-25
Journal Articles
- Evaluation of First-Line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain MetastasesChad G Rusthoven, Ajay Niranjan, Leonard C Tuanquin, Brad E Zacharia, Veronica Chiang, James B Yu, Steve Braunstein, Ayal A Aizer, Michael D Chan, Douglas Kondziolka, ..., JAMA Oncology
Authored Content
- Evaluation of First-Line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain MetastasesJune 2020
Press Mentions
Patients with Melanoma Brain Mets May Fare Better with RT Before ImmunotherapyNovember 22nd, 2024- 'Significant Milestone' for Radionuclide Therapy in Refractory MeningiomaOctober 2nd, 2024
- Neurocognitive Side Effects of Brain Radiation Subside for Many, Analysis ShowsOctober 1st, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
